Cardiomyopathies (heart muscle diseases) in children are the focus of a new scientific statement that provides insight into the diagnosis and treatment of the diseases as well as identifying future research priorities.
  • Nearly 40% of children who are diagnosed with cardiomyopathies that produce symptoms receive a heart transplant or die within the first two years after diagnosis.
  • The percentage of children with cardiomyopathy who received a heart transplant has not declined over the past 10 years. 
  • Cardiomyopathy remains the leading cause of transplantation for children over one year of age.
This Cardiac Nursing 2019 scientific program has been CME and CPD ensured. Contextual analyses in Cardiovascular Medicine, should detail a specific medical case broadcasting the background of the patient. In one portion we can discover that Case Study is a useful and explanatory part of every doctor's medical education.
  • Track 1-1 Cardiofacial Myopathy
  • Track 2-2 Dilated cardiomyopathy (DCM)
  • Track 3-3 Hypertrophic cardiomyopathy (HCM)
  • Track 4-4 Restrictive cardiomyopathy (RCM)
  • Track 5-5 Left Ventricular Non-compaction (LVNC)
  • Track 6-6 Modern practices in cardiovascular therapy
  • Track 7-7 Arrhythmogenic Right Ventricular Dysplasia (ARVD)
  • Track 8-8 Application of cardiac progenitor cells
  • Track 9-9 Cardiac Resynchronization therapy
  • Track 10-10 Cardiac rejuvenation therapy

Related Conference of Cardiology